Education
About Us
Working with TipRanks
Follow Us
Piramal Pharma Limited (IN:PPLPHARMA)
:PPLPHARMA
PPLPHARMA Analyst Ratings
Currently, no data available
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
PPLPHARMA Stock 12 Month Forecast
There Are No Analyst Ratings for IN:PPLPHARMA In The Last 3 Months.
| Highest Price Target― | Average Price Target― | Lowest Price Target― |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
PPLPHARMA Financial Forecast
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Kotak Mahindra
₹305
Buy
58.32%
Upside
Reiterated
09/29/25
Jefferies
₹260
Buy
34.96%
Upside
Initiated
08/25/25
Goldman Sachs
₹265→₹250
Buy
29.77%
Upside
Reiterated
07/15/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Kotak Mahindra
₹305
Buy
58.32%
Upside
Reiterated
09/29/25
Jefferies
₹260
Buy
34.96%
Upside
Initiated
08/25/25
Goldman Sachs
₹265→₹250
Buy
29.77%
Upside
Reiterated
07/15/25
Best Analysts Covering Piramal Pharma Limited
3 Months
xxx
Success Rate
0/3 ratings generated profit
Average Return
-9.40%
reiterated a xxx
rating 6 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -9.40% per trade.
1 Year
Success Rate
0/2 ratings generated profit
Average Return
-16.75%
reiterated a buy rating 4 months ago
Copying Alankar Garude's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -16.75% per trade.
2 Years
xxx
Success Rate
0/2 ratings generated profit
Average Return
-16.95%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -16.95% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
PPLPHARMA Analyst Recommendation Trends
Rating
Sep 25
Oct 25
Nov 25
Dec 25
Jan 26
Strong Buy
1
1
1
0
0
Buy
2
1
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
3
2
1
0
0
Each month's total comprises the sum of three months' worth of ratings.
PPLPHARMA Stock Forecast FAQ
What is IN:PPLPHARMA’s average 12-month price target, according to analysts?
Currently, no data Available
What is IN:PPLPHARMA’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for IN:PPLPHARMA, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Piramal Pharma Limited a Buy, Sell or Hold?
Currently, no data Available
What is Piramal Pharma Limited’s share price target?
Currently, no data Available
What do analysts say about Piramal Pharma Limited?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of Piramal Pharma Limited?
To buy shares of IN:PPLPHARMA, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.